Videos

Dr. Brittany Dulmage discusses how management of immune-related side effects can help patients stay on immunotherapy without compromising its effectiveness.

Drs. Nunnery and McCann discuss the evolving HER2-positive breast cancer treatment paradigm in the latest episode of “Breast Cancer Briefing.”

Dr. Christopher H. Lieu highlights the rising cancer rate in younger adults and the need for more personalized, comprehensive care strategies.

Nurse practitioner Bridget Hopkins discusses her metastatic breast cancer diagnosis, the role of clinical empathy and finding hope in stage 4 care.

Three lifelong friends, all breast cancer survivors, discuss the strength they found in supporting each other.

ctDNA testing could help doctors track response, reduce unnecessary chemo, and identify relapse early for patients with aggressive B cell lymphomas.

For patients navigating a cancer diagnosis, there is a hidden complication that requires vigilance: the risk of a pulmonary embolism.

Dr. Amengual outlines how patients with relapsed lymphoma can approach clinical trials, including phases, eligibility and key questions to ask providers.

A couple shares how self advocacy, preparation and caregiver support shaped their experience navigating liver cancer care.

The FDA approved a steroid-sparing Tecvayli and Darzalex Faspro combo for relapsed myeloma, offering an 83% reduction in disease progression risk.

Jonise S. Louis shares her journey of navigating a metastatic breast cancer diagnosis and chemotherapy while pregnant with the help of her oncology team.

A living liver donor shares recovery, fatigue and the lasting reward of helping his father heal after transplant surgery.

After a liver cancer diagnosis, one son stepped forward as a living donor, turning uncertainty into hope through a life-saving decision.

Functional precision medicine uses a patient’s tumor cells to test drugs, helping guide more personalized brain tumor treatment decisions.

Metastatic breast cancer survivor Casey Liening shares her adoption story in a candid interview.

A couple shares how open communication reshaped their relationship during and after liver cancer treatment.

For Kathy Small Wrice, a 20-year journey with multiple myeloma began not with a clear answer, but with a persistent intuition.

Shondia McFadden-Sabari of Bold and Breastless shares how intuition and early detection saved her life during a dual breast cancer diagnosis.

Paul, a liver cancer survivor, and his wife Emma share their journey of recovery, caregiving and finding balance in life after major surgeries.

Rosemary Carrera discusses her breast cancer journey, mastectomy and the personal decision to remove her implants at the Miami Breast Cancer Conference.

Survivor Casey Liening discusses her metastatic breast cancer journey, reaching NED, and why a stage 4 diagnosis is a beginning, not a death sentence.

Dr. Jennifer Amengual explains how epigenetic therapies treat lymphomas by changing gene expression rather than killing dividing cells like chemotherapy.

CURE was live on site at the the 19th Annual New York GU Cancers Congress®, where we spoke with Dr. Ulka Vaishampayan on the topic of kidney cancer.

Dr. Ajay K. Nooka, highlights how the evolution of therapy has moved the goalposts from simply achieving remission to pursuing a measurable cure.

Dr. Sandeep Kunwar explained that getting drugs into the brain is a major hurdle for glioblastoma, as the blood-brain barrier blocks most treatments.

Dr. Will Parsons, of Texas Children’s, discusses evolving therapies, survivorship clinics and tools like Passport For Care for long-term cancer care.

Dr. Nicoletta Colombo breaks down KEYNOTE B96 showing Keytruda plus paclitaxel, with or without bevacizumab, improves survival in platinum-resistant ovarian cancer.

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care.

During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.

During Kidney Cancer Awareness Month, Dr. Eric Singer shares warning signs, risk factors and when younger adults should speak with a doctor about kidney health.